Biospecific Extraction and Neutralization of Anticoagulant Heparin with Fibroblast Growth Factors (FGF)
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (10) , 2117-2127
- https://doi.org/10.1002/jps.10472
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Structural Basis for Interaction of FGF-1, FGF-2, and FGF-7 with Different Heparan Sulfate Motifs,Biochemistry, 2001
- Identification of Receptor and Heparin Binding Sites in Fibroblast Growth Factor 4 by Structure-Based MutagenesisMolecular and Cellular Biology, 2001
- FGFs, heparan sulfate and FGFRs: complex interactions essential for developmentBioEssays, 2000
- Non-Anticoagulant Heparin Increases Endothelial Nitric Oxide Synthase Activity: Role of Inhibitory Guanine Nucleotide ProteinsJournal of Molecular and Cellular Cardiology, 1998
- The Glycine Box: A Determinant of Specificity for Fibroblast Growth FactorBiochemistry, 1998
- Correlation between the 1.6 Å crystal structure and mutational analysis of keratinocyte growth factorProtein Science, 1998
- Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?Journal of Clinical Investigation, 1997
- Heparin Structure and Interactions with Basic Fibroblast Growth FactorScience, 1996
- Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repairProgress in Growth Factor Research, 1994
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983